You are here

Supportive care, cancer toxicity management, early global care: tomorrow’s issues

Presentation by Dr. Florian Scotté at the TAO Congress on 19/20 November 2015

TAO15 - FLORIAN SCOTTE- Toxicities - tomorrow's issues-HD

Dr. Florian Scotté discusses the importance of coordinating curative therapy with supportive and palliative care. Supportive care is essential, as cancer therapy is frequently interrupted or discontinued due to toxicities. This means that improving the efficacy of supportive care will also improve the efficacy of the curative treatment, and it has been shown that therapeutic progress and toxicity management jointly improve survival. Dr. Scotté therefore calls for a multidisciplinary approach which includes all health professionals. He also reviews efficacy and safety data from several trials. Another essential point is patient-centered care, based on patient-reported outcomes as new assessment instrument. Dr. Scotté presents the “NEXT PROCHE” programme, which has been developed by the European Hospital Georges Pompidou. The objective of this programme is to link precision medicine and personalized medicine. It features an application for following up cancer patients, enabling a better coordination between hospitals and other healthcare providers and taking into account the patient’s personal environment.

Dr. Florian Scotté, Hôpital Européen Georges Pompidou, Paris, France

Search this site

Stay up-to-date with our monthly e-alert

If you want to regularly receive information on what is happening in Quality of Life in Oncology research sign up to our e-alert.

Subscribe »

QOL (Quality of Life) newsletter e-alert

NEW! Free access to the digital version of a new publication in Cancer Supportive Care

Cancer cachexia: mechanisms and progress in treatment

Authors: Egidio Del Fabbro, Kenneth Fearon, Florian Strasser

This book was supported by an educational grant from Helsinn Healthcare SA.

Featured videos

Quality of Life promotional video

Made possible by an educational grant from Helsinn

Helsinn does not have any influence on the content and all items are subject to independent peer and editorial review

Society Partners

European Cancer Organisation Logo